Banking & Finance  January 23, 2015

PanTheryx adds nearly $3 million to funding round

BOULDER – Biotechnology company PanTheryx Inc. is nearing the three-quarter mark in its effort to raise $10 million, according to a recent regulatory filing with the Securities and Exchange Commission.

Boulder-based PanTheryx has raised $7.3 million of the round that began in April 2013 through equity investments and issuing warrants and options. PanTheryx reported it had raised $4.4 million of its goal in March of last year.

PanTheryx, headed by president and chief executive Mark Braman, is working on medical nutrition products, including a treatment for children with infectious diarrhea that has shown in clinical trials to be safe and effective in replenishing nutrients lost during a bout with the disease.

SPONSORED CONTENT

Business Cares: March 2024

WomenGive, a program of United Way of Larimer County, was started in Larimer County in 2006 as an opportunity for women in our community to come together to help other women.

The company also is working on foods as dietary supplements to help healthy people maintain intestinal health, and medical foods for dietary management that would be used under medical supervision.

Diarrhea, the company said, is a life-threatening global health concern, representing 11 percent of child deaths worldwide, second only to pneumonia. The World Health Organization estimates that worldwide there are 1.7 billion infectious diarrhea cases annually among children younger than age 5. Nearly 1 million children die each year from diarrhea complications, killing more children than AIDS, malaria and measles combined.

In addition to Braman, Scott Hyman and George Stagnitti are listed as executive officers of the company. Tom Washing and David Cook are listed as company directors. Washing is a partner at Sequel Venture Partners LLC, a venture capital firm in Boulder. Cook is a retired lawyer from the local office of Faegre Baker Daniels LLP. He received the Esprit Entrepreneur Lifetime Achievement Award from the Boulder Chamber in 2005.

BOULDER – Biotechnology company PanTheryx Inc. is nearing the three-quarter mark in its effort to raise $10 million, according to a recent regulatory filing with the Securities and Exchange Commission.

Boulder-based PanTheryx has raised $7.3 million of the round that began in April 2013 through equity investments and issuing warrants and options. PanTheryx reported it had raised $4.4 million of its goal in March of last year.

PanTheryx, headed by president and chief executive Mark Braman, is working on medical nutrition products, including a treatment for children with infectious diarrhea that has shown in clinical trials to be safe and effective in…

Sign up for BizWest Daily Alerts